Argent Biopharma Limited has released a press release.
Strategic Collaboration Agreement for Malta Facility
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Argent Biopharma
- CannEpil Receives Approval for Prescription in Germany
- CimetrA Phase IIb Clinical Trial Results
- Argent BioPharma Expands Pipeline with Promising Drug CimetrA®
- Exclusive Agreement for Malta Manufacturing Facility
- Strategic Manufacturing Partnership with ECCPharm Limited
Later from Argent Biopharma
- Strategic Agreement to Enhance Cannabinoid Development
- Argent BioPharma Enters Germany - Europe's Largest Market
- EU-GMP Cannabinoid API Supplied for Epilepsy in Slovenia
- RGT Signs Binding Term Sheet to Acquire AusCann Assets
- U.S. In Vivo Study Supports ArtemiC Efficacy
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma